Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology
source: Blood
year: 2016
authors: Zhang D, Xu C, Manwani D, Frenette PS
summary/abstract:Sickle cell disease (SCD) is a severe genetic blood disorder characterized by hemolytic anemia, episodic vaso-occlusion, and progressive organ damage. Current management of the disease remains symptomatic or preventative. Specific treatment targeting major complications such as vaso-occlusion is still lacking. Recent studies have identified various cellular and molecular factors that contribute to the pathophysiology of SCD. Here, we review the role of these elements and discuss the opportunities for therapeutic intervention.
organization: Ruth L. and David S. Gottesman Institute for Stem Cell and Regenerative Medicine Research,Albert Einstein College of Medicine, Bronx, NYDOI: 10.1182/blood-2015-09-618538
read more full text
+myBinderRelated Content
-
The spectrum of sickle hemoglobin-related nephropathy: from sickle cell disease to sickle traitRenal dysfunction is among the most comm...
-
University researchers develop more complete model of sickle cellUniversity researchers have developed co...
-
Microparticles in sickle cell anaemia: promise and pitfallsBlood from patients with sickle cell dis...
-
Researchers ID key drivers of heart complications in sickle cell anemiaStudy opens path to earlier diagnosis, t...
-
Chip-based Models Mimic Organs to Advance Understanding of Sickle Cell DiseaseResearchers at Mississippi State Univers...
-
Corinna Schultz, MD: Does Sickle Cell Trait Get Discussed?According to data presented tonight at t...
-
Marina Jerebtsova, PhDDr Marina Jerebtsova is an assistant pro...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.